Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Search content at Albert Einstein College of Medicine
Home
Faculty
Departments
Grants
Publications
Prizes
Chemotherapy-induced cardiotoxicity in children
Neha Bansal
, Shahnawaz Amdani
, Emma R. Lipshultz
, Steven E. Lipshultz
Research output
:
Contribution to journal
›
Review article
›
peer-review
80
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Chemotherapy-induced cardiotoxicity in children'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Anthracyclines
100%
Chemotherapy-induced Cardiotoxicity
100%
Cardiotoxicity
83%
Dexrazoxane
33%
Cardioprotectant
33%
Preventive Strategies
16%
Young Age
16%
High Dose
16%
Treatment-related
16%
Cardiovascular Complications
16%
Chemotherapy
16%
Paucity
16%
Cancer Therapy
16%
Preventive Measures
16%
Long Follow-up
16%
Expert Opinion
16%
Cumulative Dose
16%
Subclinical Cardiovascular Disease
16%
Female Sex
16%
Primary Prevention
16%
Area Cover
16%
Structural Analogues
16%
Adverse Cardiac Events
16%
Evidence-based Recommendations
16%
Anthracycline-induced Cardiotoxicity
16%
Cardiac Effects
16%
Cancer Survivors
16%
Driver mutations
16%
Personalized Cancer Therapy
16%
Cardioprotective Agents
16%
Mortality Burden
16%
Morbidity Burden
16%
Cardiovascular Status
16%
Cardiac Damage
16%
Clinical Oncology
16%
Anthracycline Chemotherapy
16%
Cardio-oncology
16%
Cardiac Irradiation
16%
During Treatment
16%
Evidence-based Support
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiotoxicity
100%
Anthracycline
100%
Chemotherapy Regimens
100%
Malignant Neoplasm
37%
Razoxane
25%
Cardiovascular Disease
25%
Morbidity
12%
Pathophysiology
12%
Heart Injury
12%
Cardiac Side Effect
12%